全球細胞分散市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計細胞分離市場將從 2025 年的 4.788 億美元成長到 2034 年的 15.3383 億美元，2026 年至 2034 年的複合年成長率為 13.81%。

受細胞生物學、再生醫學和癌症研究領域日益活躍的研究活動推動，全球細胞分離市場正經歷穩定成長。細胞分離技術對於從組織中分離單一細胞以進行實驗室分析和治療應用至關重要。生物技術和製藥研究投入的增加也促進了市場擴張。幹細胞研究和個人化醫療需求的成長進一步推動了產品應用。

關鍵成長要素包括生物製藥生產的擴張和人們對細胞療法日益成長的關注。酶法和非酶法分離方法在實驗室和臨床環境中已廣泛應用。自動化細胞處理系統的進步提高了效率和可重複性。此外，政府對生命科學研究的資助以及慢性病發病率的上升也促進了對先進細胞分析工具的需求成長。

隨著臨床試驗的增加和細胞療法的商業化程度提高，預計未來市場將持續擴張。旨在提高細胞活力和降低污染風險的技術創新將推動產品研發。新興市場對醫療研究基礎設施的投資有望開闢新的成長途徑。隨著再生醫學和精準醫學的不斷進步，全球細胞分離市場有望保持持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球細胞分散市場：依產品分類

• 市場分析、洞察與預測
• 酵素解離
• 非酵素解離
• 設備和配件

第5章：全球細胞分散市場：依類型分類

• 市場分析、洞察與預測
• 組織分離
• 細胞脫落

第6章：全球細胞分散市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 研究和學術機構

第7章 全球細胞分散市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck KGaA
  • Thermo Fisher Scientific
  • Danaher Corp
  • STEMCELL Technologies
  • Sartorius AG
  • BD
  • Miltenyi Biotec
  • PAN-Biotech
  • HiMedia Laboratories
  • F. Hoffmann-La Roche Ltd
  • S2 Genomics Inc

The Cell Dissociation Market size is expected to reach USD 1533.83 Million in 2034 from USD 478.80 Million (2025) growing at a CAGR of 13.81% during 2026-2034.

The Global Cell Dissociation Market is witnessing steady growth due to rising research activities in cell biology, regenerative medicine, and cancer studies. Cell dissociation techniques are essential for isolating individual cells from tissues for laboratory analysis and therapeutic applications. Increasing investments in biotechnology and pharmaceutical research are supporting market expansion. Growing demand for stem cell research and personalized medicine is further driving product adoption.

Key growth drivers include the expansion of biopharmaceutical production and increasing focus on cell-based therapies. Enzymatic and non-enzymatic dissociation methods are widely used in research laboratories and clinical settings. Advancements in automated cell processing systems are improving efficiency and reproducibility. Additionally, government funding for life sciences research and rising prevalence of chronic diseases are contributing to higher demand for advanced cell analysis tools.

In the future, the market is expected to expand with growing clinical trials and commercialization of cell therapies. Innovations aimed at improving cell viability and reducing contamination risks will enhance product development. Emerging markets investing in healthcare research infrastructure will create new growth avenues. As regenerative medicine and precision healthcare continue to advance, the Global Cell Dissociation Market is likely to witness sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Enzymatic Dissociation
• Non-enzymatic Dissociation
• Instruments & Accessories

By Type

• Tissue Dissociation
• Cell Detachment

By End Use

• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutes

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific, Danaher Corp, STEMCELL Technologies, Sartorius AG, BD, Miltenyi Biotec, PANBiotech, HiMedia Laboratories, F HoffmannLa Roche Ltd, S2 Genomics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL DISSOCIATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Enzymatic Dissociation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-enzymatic Dissociation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Instruments & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL DISSOCIATION MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Tissue Dissociation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cell Detachment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL DISSOCIATION MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL DISSOCIATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Type
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Type
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Type
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Type
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Type
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL DISSOCIATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Merck KGaA
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 Danaher Corp
  • 9.2.4 STEMCELL Technologies
  • 9.2.5 Sartorius AG
  • 9.2.6 BD
  • 9.2.7 Miltenyi Biotec
  • 9.2.8 PAN-Biotech
  • 9.2.9 HiMedia Laboratories
  • 9.2.10 F. Hoffmann-La Roche Ltd
  • 9.2.11 S2 Genomics Inc